当前位置:首页 - 行情中心 - 毕得医药(688073) - 财务分析 - 现金流量表

毕得医药

(688073)

  

流通市值:30.34亿  总市值:63.78亿
流通股本:4323.42万   总股本:9088.29万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金586,736,609.13265,740,677.841,209,740,796.66826,956,332.59
  收到的税费返还26,658,135.8513,185,269.2851,239,555.2837,423,828.32
  收到其他与经营活动有关的现金17,768,672.678,054,209.2732,732,431.2325,606,716.11
  经营活动现金流入小计631,163,417.65286,980,156.391,293,712,783.17889,986,877.02
  购买商品、接受劳务支付的现金463,776,403.62221,036,451.81796,024,972.78547,517,198.32
  支付给职工以及为职工支付的现金89,201,273.542,004,303.87182,664,881.06127,648,964.92
  支付的各项税费26,321,524.015,882,701.2171,008,649.3453,293,563.62
  支付其他与经营活动有关的现金35,752,027.9310,960,140.5185,701,574.4860,977,194.79
  经营活动现金流出小计615,051,229.06279,883,597.41,135,400,077.66789,436,921.65
  经营活动产生的现金流量净额16,112,188.597,096,558.99158,312,705.51100,549,955.37
二、投资活动产生的现金流量:
  收回投资收到的现金1,991,444,472.6395,000,000686,081,482356,000,000
  取得投资收益收到的现金2,766,843.681,261,004.664,849,668.41884,561.59
  处置固定资产、无形资产和其他长期资产收回的现金净额2,798,776.36317,023.112,197,6882,325,962.01
  收到的其他与投资活动有关的现金4,208,951-1,148,368.751,043,621.97
  投资活动现金流入小计2,001,219,043.6796,578,027.77694,277,207.16360,254,145.57
  购建固定资产、无形资产和其他长期资产支付的现金5,875,730.96918,132.5688,346,161.8774,003,767.26
  投资支付的现金2,377,375,467837,375,467764,000,000636,000,000
  支付其他与投资活动有关的现金16,544,185.2-408,705.22-
  投资活动现金流出小计2,399,795,383.16838,293,599.56852,754,867.09710,003,767.26
  投资活动产生的现金流量净额-398,576,339.49-741,715,571.79-158,477,659.93-349,749,621.69
三、筹资活动产生的现金流量:
  取得借款收到的现金268,028,272.07231,501,858.6297,345,972.59112,168,202.17
  收到其他与筹资活动有关的现金2,982,515.56-7,598,915.93-
  筹资活动现金流入小计271,010,787.63231,501,858.62104,944,888.52112,168,202.17
  偿还债务支付的现金98,057,882.159,103,984.7268,010,841.9354,008,854.18
  分配股利、利润或偿付利息支付的现金78,329,965.841,683,600.479,879,711.7479,587,450.01
  支付其他与筹资活动有关的现金102,040,775.1635,992,612.71123,896,503.61114,189,210.31
  筹资活动现金流出小计278,428,623.1546,780,197.83271,787,057.28247,785,514.5
  筹资活动产生的现金流量净额-7,417,835.52184,721,660.79-166,842,168.76-135,617,312.33
四、汇率变动对现金及现金等价物的影响3,350,488.572,458,750.34-1,442,233.01-1,339,636.09
五、现金及现金等价物净增加额-386,531,497.85-547,438,601.67-168,449,356.19-386,156,614.74
  加:期初现金及现金等价物余额1,096,620,698.251,096,620,698.251,265,070,054.441,265,070,054.44
  期末现金及现金等价物余额710,089,200.4549,182,096.581,096,620,698.25878,913,439.7
补充资料:
  净利润73,406,059.54-117,426,163.51-
  资产减值准备18,647,601.9-33,826,019.95-
  固定资产和投资性房地产折旧6,473,364.27-10,741,443.13-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧6,473,364.27-10,741,443.13-
  无形资产摊销235,135.83-393,450.95-
  长期待摊费用摊销5,023,424.01-14,985,390.39-
  处置固定资产、无形资产和其他长期资产的损失-330,567.88--856,347.2-
  固定资产报废损失--27,481.45-
  公允价值变动损失-742,557.99--3,148,107.01-
  财务费用6,351,997.46-4,018,176.58-
  投资损失-6,707,093.94--1,619,012.09-
  递延所得税-3,552,891.63-2,749,453.76-
  其中:递延所得税资产减少-1,778,637.35-3,615,543.86-
    递延所得税负债增加-1,774,254.28--866,090.1-
  存货的减少-107,216,108.43--96,645,352.13-
  经营性应收项目的减少-6,627,240.26-10,045,537.42-
  经营性应付项目的增加19,658,046.64-43,195,682.69-
  其他--1,692,298.98-
  不涉及现金收支的投资和筹资活动金额其他项目525,818.16-18,529,789.18-
  现金的期末余额710,089,200.4-1,096,620,698.25-
  减:现金的期初余额1,096,620,698.25-1,265,070,054.44-
  现金及现金等价物的净增加额-386,531,497.85--168,449,356.19-
公告日期2025-08-222025-04-242025-04-242024-10-24
审计意见(境内)标准无保留意见
TOP↑